Meta-Analysis Study: Mycophenolate Mofetil Is More Effective Than Azathioprine in Achieving Remission in Autoimmune Hepatitis
by dr. Nugroho Nitiyoso, MBA
| 24 March 2026
Autoimmune hepatitis (AIH) is a rare, chronic, progressive inflammatory liver disease mediated by the immune system. If left untreated, AIH can lead to serious complications such as ascites, fibrosis, cirrhosis, liver failure, and even death. In addition to the standard treatments currently in use, several recent studies have highlighted mycophenolate mofetil as a potential alternative.